Tuesday, September 29, 2020
AngioDynamics Reports Fiscal 2021 First Quarter Financial Results
Fiscal 2021 First Quarter Highlights Net sales of $70.2 million increased 6.3% compared to the prior-year quarter, inclusive of the previously disclosed $5.2 million order from the National Health Service ( NHS ) in the UK Gross margin declined 700 basis points year over year to 50.9% GAAP loss per...

  Monday, September 21, 2020
AngioDynamics Announces Commercial Launch of Auryon Atherectomy System in United States
ADVANCED MEDICAL TECHNOLOGY SAFELY 1 & EFFECTIVELY TREATS PAD, CLI, ISR LATHAM, N.Y. --(BUSINESS WIRE)--Sep. 21, 2020-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today...

  Thursday, September 17, 2020
AngioDynamics to Report Fiscal 2021 First Quarter Financial Results on September 29, 2020
LATHAM, N.Y. --(BUSINESS WIRE)--Sep. 17, 2020-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the first quarter of...

  Monday, August 17, 2020
AngioDynamics Announces First Patient Enrolled in PATHFINDER I Registry Examining Long-Term Effectiveness and Safety of Auryon Atherectomy System
LATHAM, N.Y. --(BUSINESS WIRE)--Aug. 17, 2020-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced the enrollment of the first patient in the PATHFINDER I:...

  Monday, August 3, 2020
AngioDynamics to Participate in a Virtual Fireside Chat at the Canaccord Genuity Growth Conference
LATHAM, N.Y. --(BUSINESS WIRE)--Aug. 3, 2020-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer , President and Chief Executive Officer, will...

  Thursday, July 16, 2020
AngioDynamics Reports Fiscal 2020 Fourth Quarter and Full-Year Financial Results
Fiscal 2020 Fourth Quarter Highlights Net sales of $58.3 million decreased 18.1% compared to the prior-year quarter Gross margin declined 630 basis points year over year to 51.8% GAAP loss per share of $4.10 , inclusive of approximately $4.14 of goodwill impairment; adjusted loss per share of $0.06...

  Tuesday, June 23, 2020
AngioDynamics to Report Fiscal 2020 Fourth Quarter and Full-Year Financial Results on July 16, 2020
LATHAM, N.Y. --(BUSINESS WIRE)--Jun. 23, 2020-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the fourth quarter and...

  Monday, June 8, 2020
AngioDynamics to Participate in a Virtual Fireside Chat at the Raymond James Human Health Innovation Conference
LATHAM, N.Y. --(BUSINESS WIRE)--Jun. 8, 2020-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer , President and Chief Executive Officer, and...

  Thursday, May 7, 2020
AngioDynamics to Present at the UBS Virtual Global Healthcare Conference
LATHAM, N.Y. --(BUSINESS WIRE)--May 7, 2020-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer , President and Chief Executive Officer, and...

  Tuesday, April 7, 2020
AngioDynamics Reports Fiscal 2020 Third Quarter Financial Results
Fiscal 2020 Third Quarter Highlights Net sales of $69.8 million increased 6.5% compared to the prior-year quarter Gross margin declined 40 basis points to 57.8% year over year GAAP loss per share of $0.15 ; adjusted earnings per share of $0.01 Launched PATHFINDER I Registry to evaluate performance...

  Tuesday, March 10, 2020
AngioDynamics to Report Fiscal 2020 Third Quarter Financial Results on April 7, 2020
LATHAM, N.Y. --(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the third quarter of fiscal year 2020...

  Thursday, February 27, 2020
AngioDynamics to Present at Two Investor Conferences in March
LATHAM, N.Y. --(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will present at the following two investor conferences in March:...

  Thursday, February 6, 2020
AngioDynamics Appoints Stephen Trowbridge Executive Vice President and Chief Financial Officer
LATHAM, N.Y. --(BUSINESS WIRE)--Feb. 6, 2020-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it has appointed Stephen Trowbridge to the role of Executive...

  Thursday, January 16, 2020
AngioDynamics Launches PATHFINDER I Registry to Evaluate Performance and Clinical Outcomes of the AURYON™ Atherectomy System
LATHAM, N.Y. --(BUSINESS WIRE)--Jan. 16, 2020-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced the launch of the PATHFINDER I: Post-Market Registry (PATHFINDER...

  Tuesday, January 7, 2020
AngioDynamics Reports Fiscal 2020 Second Quarter Financial Results
Fiscal 2020 Second Quarter Highlights Net sales of $70.0 million , flat compared to the prior-year quarter Gross margin increased 140 basis points year over year to 59.3% GAAP loss per share of $0.07 ; adjusted earnings per share of $0.06 Announces the acquisition of C3 Wave PICC tip location...